SCHEMBL190684

SCHEMBL190684

Cc1cccc(C)c1Oc1ccnc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.41
AR P10275 1/20 0.39
FFAR1 O14842 1/20 0.36
PPARG P37231 1/20 0.36
GCK P35557 1/20 0.36
GRM5 P41594 2/20 0.35
TRPA1 O75762 1/20 0.35
SRC P12931 1/20 0.34
RECQL P46063 1/20 0.34
LOX P28300 1/20 0.34
LOXL3 P58215 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NFE2L2 Q16236 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6232217 0.83 POLB (0.37) PPARGRECQLLOXLOXL3LOXL2
SCHEMBL16187041 0.83 KDM4E (0.39) HSP90AA1RECQLLOXLOXL3LOXL2
SCHEMBL192869 0.82 SMN1; SMN2 (0.40) PPARGGCKGRM5TRPA1RECQL
SCHEMBL190888 0.79 GCK (0.51) HSP90AA1GCKGRM5TRPA1RECQL
SCHEMBL16187042 0.77 MEN1 (0.43) MEN1KMT2AHTT
SCHEMBL191463 0.76 SMN1; SMN2 (0.50) GRM5MEN1KMT2AHTTKDM4E
SCHEMBL16076004 0.75 SCN9A (0.38) PPARGLOXLOXL3LOXL2MEN1
SCHEMBL16058868 0.75 SCN9A (0.31) PPARG
SCHEMBL29048001 0.75 SCN5A (0.49) ARPPARGGRM5MEN1KMT2A
SCHEMBL8237311 0.75 TEAD4 (0.44) ARPPARGMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 HSP90AA1 1662/4885AR 4276/4885FFAR1 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.